Alarming India-wide phenomenon of antifungal resistance in dermatophytes: A multicentre study

Andreas Ebert1,2, Michel Monod3, Karine Salamin3

  • 1Medizinische Fakultät, Universität Leipzig, Leipzig, Germany.

Mycoses
|April 18, 2020
PubMed
Abstract

Insights

Recalcitrant dermatophytosis is rising in India, with 71% of fungal isolates showing terbinafine resistance. Key mutations in the squalene epoxidase gene are linked to this drug resistance.

Area of Science:

  • Medical Mycology
  • Antimicrobial Resistance
  • Molecular Biology

Background:

  • Increasing prevalence of difficult-to-treat fungal skin infections (dermatophytosis) in India.
  • Suspected role of antifungal drug resistance in treatment failures.

Purpose of the Study:

  • Determine in vitro resistance of dermatophytes to terbinafine, itraconazole, and voriconazole.
  • Identify mutations in the fungal squalene epoxidase (SQLE) gene associated with resistance.

Main Methods:

  • Analysis of 402 skin samples from diverse Indian locations.
  • Microbiological and molecular identification of fungal species.
  • Antifungal susceptibility testing and SQLE gene sequencing.

Main Results:

  • Trichophyton mentagrophytes (ITS Type VIII) was the predominant species (78%).
  • High terbinafine resistance (71%) observed in isolates.
  • Prevalence of Phe397Leu substitution in SQLE of resistant T. mentagrophytes (91%); novel Ser395Pro and Ser443Pro substitutions identified.

Conclusions:

  • Alarming terbinafine resistance rates in Indian dermatophytes necessitate monitoring.
  • SQLE gene substitutions (Leu393-Ser443) show potential as future resistance markers.